Department of Health
and Human Services (HHS)
and Human Services (HHS)
October 13, 2020
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-19-315 "Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)". Specifically, the remaining 3 dates have changed. See changes in bold italics below.
Currently Reads:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) |
September 4, 2019; February 14, 2020; July 20, 2020; February 17, 2021; July 19, 2021; and February 14, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
September 7, 2019; May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; and May 7, 2022 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | November 2019; June 2020; November 2020; June 2021; November 2021 and June 2022 |
| Advisory Council Review | January 2020; October 2020; January 2021; October 2021; January 2022; and October 2022 |
| Earliest Start Date | April 2020 |
| Expiration Date | March 08, 2022 |
Modified to Read:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) |
September 4, 2019; February 14, 2020; July 20, 2020; February 22, 2021; June 22, 2021; and February 22, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) |
September 7, 2019; May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; and May 7, 2022 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | November 2019; June 2020; November 2020; June 2021; November 2021 and June 2022 |
| Advisory Council Review | January 2020; October 2020; January 2021; October 2021; January 2022; and October 2022 |
| Earliest Start Date | April 2020 |
| Expiration Date | May 08, 2022 |
All other aspects of this FOA remain unchanged.
Mary Ann Pelleymounter, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: mary.pelleymounter@nih.gov